SCHEMBL7659816

SCHEMBL7659816

Fc1ccc(Oc2sc3ccccc3c2Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ OGG1 O15527 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MCL1 Q07820 1/20 0.39
▸ PRNP P04156 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ IDO1 P14902 1/20 0.38
▸ PTGS2 P35354 1/20 0.37
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670984 0.87 LOXL2 (0.43) ESR1LOXL2OGG1ALDH1A1CYP1A2
SCHEMBL7662066 0.84 LOXL2 (0.41) LOXL2OGG1ALDH1A1MCL1NPSR1
SCHEMBL7662062 0.84 MAPT (0.55) LOXL2ALDH1A1MCL1NPSR1RXFP1
SCHEMBL7668527 0.80 TRPA1 (0.45) LOXL2OGG1ALDH1A1CYP1A2CYP3A4
SCHEMBL7661911 0.75 LOXL2 (0.42) LOXL2OGG1ALDH1A1CYP1A2MCL1
SCHEMBL7879489 0.74 TDP1 (0.44) LOXL2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL7667320 0.73 LOXL2 (0.43) LOXL2OGG1ALDH1A1CYP1A2MCL1
SCHEMBL7674113 0.72 ALOX5 (0.41) LOXL2OGG1ALDH1A1CYP1A2CYP2C19
SCHEMBL7662088 0.72 L3MBTL1 (0.40) LOXL2ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL7671893 0.72 LOXL2 (0.39) LOXL2OGG1ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback